In GBM, neurofibromin, the NF1 gene product, negatively regulates mTOR signaling through downregulation of the Ras/MAPK pathway, hyperactivation of mTOR, and increased cell proliferation, favoring tumor progression [70]. This evidence concerns the gene MTOR and glioblastoma.